Change of Immune Cell of ARDS Patients：an Observational Study

• Conditions: Intensive Care Medicine; ARDS

• Registration Number: NCT02958748
• Lead Sponsor: Southeast University, China

Brief Summary

To evaluate change of different immune cellsduring ARDS and its impact on prognosis.

Detailed Description

Not available

Study Timeline

• Status Verified: 2016-11
• Study Start: 2016-11
• Study First Submitted: 2016-11-06
• Study First Submitted QC: 2016-11-06
• Last Update Submitted: 2016-11-06
• Study First Posted: 2016-11-08
• Last Update Posted: 2016-11-08
• Primary Completion: 2018-11

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

①sign on the acknowledged

②Diagnosis with ARDS(The Berlin definition），onset within 48hours

Exclusion Criteria

①diagnosis of hematological or immunological disease

②treatment with chemotherapy agents or corticosteroids within 6 months prior to or during the hospitalization.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
mortality	28-day